Clinical significance of anti-Ro and Anti-La antibodies: The role of isolated anti-La

ObjectivesThe aim of the present study was to describe demographic, clinical, and immunological characteristics of SLE patients with anti-La/SSB antibodies positive versus anti-La/SSB negative patients.MethodsRetrospective cross-sectional study, including all patients with SLE (≥4 ACR-1997 criteria) recruited in RELESSER registry. Sociodemographic, clinical, serological and comorbidities variables were collected. Anti-Ro-/La + patients were compared with the rest of the patients.ResultsIn a study involving 4219 systemic lupus erythematosus (SLE) patients, 44/3893 (1.1%) were found to be positive for isolated anti-La/SSB antibodies. The mean age was 33.77 years, with a majority being female (88.6%) and Caucasian (90.5%). The most frequent comorbidities were smoking (48.8%), dyslipidemia (47.7%), and arterial hypertension (31.8%). Photosensitivity and mucosal ulcers were more common in anti-Ro+/La + patients compared to anti-Ro+/La- and anti-Ro-/La- patients. Anti-Ro+/La + patients had a lower frequency of lupus nephritis compared to anti-Ro+/La- patients. A multivariable regression model, considering various confounding factors, was applied to compare anti-La/SSB positive patients with negative ones. Isolated anti-La/SSB positive patients showed a lower occurrence of lupus nephritis and a higher frequency of cardiac manifestations.ConclusionsThe study suggests that patients with isolated anti-La/SSB antibodies may have a unique clinical profile, with a potential protective effect against lupus nephritis but an increased likelihood of cardiac manifestations.

Authors

Institutions

Publication Details

Journal
Lupus
Published
2025-04-01
DOI
https://doi.org/10.1177/09612033251331249
Primary Topic
Systemic Lupus Erythematosus Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical significance of anti-Ro and Anti-La antibodies: The role of isolated anti-La

Mónica Ibáñez Barceló, Javier Narváez, E. Tomero Muriel, Eva Salgado-Pérez et al.
Lupus
Systemic Lupus Erythematosus Research
article

Clinical significance of anti-Ro and Anti-La antibodies: The role of isolated anti-La

Mónica Ibáñez Barceló, Javier Narváez, E. Tomero Muriel, Eva Salgado-Pérez, Íñigo Rúa‐Figueroa, O. Ibarguengoitia, Carlos Montilla, Rocío Caño, Ángela Pecondón, Clara Sangüesa Gómez, Julia Martínez‐Barrio, María Jesús García-Villanueva, Víctor Quevedo Vila, Antonio Fernández‐Nebro, Loreto Horcada, José María Pego‐Reigosa, Jaime Calvo‐Alén, María Galindo-Izquierdo, Nuria Lozano‐Rivas, Paloma Vela, Tomás Ramón Vázquez Rodríguez, José Luís Andreu, Tarek Carlos Salman-Monte, Lorena Expósito, Beatriz Romero, Mercedes Freire González, Víctor M. Martínez-Taboada, Virginia Moreira, Gema Bonilla Hernán, Elena Aurrecoechea Aguinaga, Irene Altabás González, Alejandro Olivé, Gregorio Santos Soler, Javier Nóvoa, Vicente Torrente-Segarra, E. Uriarte Isacelaya, Raúl Menor Almagro, A. Pérez Gómez, Clara Moriano Morales, Joan Calvet Fontonova
article en

Abstract

ObjectivesThe aim of the present study was to describe demographic, clinical, and immunological characteristics of SLE patients with anti-La/SSB antibodies positive versus anti-La/SSB negative patients.MethodsRetrospective cross-sectional study, including all patients with SLE (≥4 ACR-1997 criteria) recruited in RELESSER registry. Sociodemographic, clinical, serological and comorbidities variables were collected. Anti-Ro-/La + patients were compared with the rest of the patients.ResultsIn a study involving 4219 systemic lupus erythematosus (SLE) patients, 44/3893 (1.1%) were found to be positive for isolated anti-La/SSB antibodies. The mean age was 33.77 years, with a majority being female (88.6%) and Caucasian (90.5%). The most frequent comorbidities were smoking (48.8%), dyslipidemia (47.7%), and arterial hypertension (31.8%). Photosensitivity and mucosal ulcers were more common in anti-Ro+/La + patients compared to anti-Ro+/La- and anti-Ro-/La- patients. Anti-Ro+/La + patients had a lower frequency of lupus nephritis compared to anti-Ro+/La- patients. A multivariable regression model, considering various confounding factors, was applied to compare anti-La/SSB positive patients with negative ones. Isolated anti-La/SSB positive patients showed a lower occurrence of lupus nephritis and a higher frequency of cardiac manifestations.ConclusionsThe study suggests that patients with isolated anti-La/SSB antibodies may have a unique clinical profile, with a potential protective effect against lupus nephritis but an increased likelihood of cardiac manifestations.

LupusVol. 34(6)
Universidade da Coruña (ES), Hospital Universitario Insular de Gran Canaria (ES), Hospital Universitario de Canarias (ES), Hospital Universitario La Paz (ES), Bellvitge University Hospital (ES), University Hospital Complex Of Vigo (ES), Hospital General Universitario Gregorio Marañón (ES), Hospital Son Llatzer (ES), Hospital Universitario Virgen Macarena (ES), Hospital de Basurto (ES), Complejo Hospitalario de Navarra (ES), Hospital Universitario de Gran Canaria Doctor Negrín (ES), Hospital Leforte (BR), Complejo Hospitalario de Salamanca (ES), Marqués de Valdecilla University Hospital (ES), Biogipuzkoa Health Research Institute (ES), Hospital Universitario 12 De Octubre (ES), Hospital Sierrallana (ES), Hospital Universitario Puerta de Hierro Majadahonda (ES), Hospital Universitario Príncipe de Asturias (ES), Hospital Regional Universitario de Málaga (ES), Hospital Universitario Araba (ES), Hospital Universitario Miguel Servet (ES), Corporació Sanitària Parc Taulí (ES), Hospital Universitario de La Princesa (ES), Hospital Del Mar (ES), Hospital de Sant Joan Despí Moisès Broggi (ES), Hospital General Universitario de Alicante Doctor Balmis (ES), Hospital Universitario Lucus Augusti (ES), Hospital Universitario Virgen de la Arrixaca (ES), Fundación Canaria de Investigación Sanitaria (ES), Hospital Universitari Germans Trias i Pujol (ES), Hospital Jerez Puerta del Sur (ES), Hospital Marina Baixa (ES), Hospital Universitario Severo Ochoa (ES), Hospital Universitario de León (ES), Hospital Universitario Infanta Sofía (ES), Hospital Universitario Ramón y Cajal (ES), Complejo Hospitalario de Ourense (ES)
Good health and well-being
Openalex Percentile: Top 90%
Systemic Lupus Erythematosus Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.